These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6966456)

  • 1. Hemodynamic, electrocardiographic and toxic effects of the intravenous administration of increasing doses of mexiletine in the dog. Comparison with similar effects produced by other antiarrhythmics.
    Carlier J
    Acta Cardiol Suppl; 1980; (25):81-100. PubMed ID: 6966456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Toxic and hemodynamic effects of aprindine in the dog. Comparison with other anti-arrhythmia agents].
    Lisin N; Carlier J
    Acta Cardiol; 1974; Suppl 18():117-30. PubMed ID: 4547497
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemodynamic effects of an intravenous injection of mexiletine in patients hospitalised in intensive care units.
    Henrard L; Carlier J
    Acta Cardiol Suppl; 1980; (25):101-7. PubMed ID: 6966451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SC-36602, a new antiarrhythmic agent: comparison of its cardiovascular profile with that of other antiarrhythmic drugs.
    Frederick LG; Hatley FR; McDonald SJ; Stamm MH; Garthwaite SM
    J Cardiovasc Pharmacol; 1988 Jun; 11(6):657-66. PubMed ID: 2457760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative haemodynamic effects of lidocaine, mexiletine, and disopyramide.
    Beltrame J; Aylward PE; McRitchie RJ; Chalmers JP
    J Cardiovasc Pharmacol; 1984; 6(3):483-90. PubMed ID: 6202976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of parenteral and oral mexiletine.
    Renard M; de Hemptinne J; Gillet JM; Bernard R
    Acta Cardiol Suppl; 1980; (25):75-80. PubMed ID: 6966455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative studies on the cardiodepressant effect of disopyramide, mexiletine and propafenon].
    Angermann C; Jahrmärker H
    Z Kardiol; 1983 Nov; 72(11):665-74. PubMed ID: 6659643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intropic effects of several antiarrhythmic drugs.
    Ferro G; Chiariello M; Tari MG; Vigorito C; Ungaro B; Condorelli M
    Jpn Heart J; 1983 May; 24(3):377-90. PubMed ID: 6876382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of mexiletine and disopyramide after cardioplegic arrest.
    Moritz A; Eckersberger F; Losert U; Probst P; Schreiner W; Wolner E
    Eur Surg Res; 1989; 21(6):327-35. PubMed ID: 2633930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodynamic repercussions and clinical tolerance of 6 class I anti-arrhythmia agents in acute myocardial infarction].
    Bernard R; Renard M; Shita A; de Hemptinne J; Gillet JM; Lewinson H; Liebens I; Waterschoot P
    Ann Cardiol Angeiol (Paris); 1986 Apr; 35(4):195-8. PubMed ID: 3090925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative antidysrhythmic and haemodynamic effects of orally or intravenously administered mexiletine and ORG 6001 in the anaesthetized rat.
    Marshall RJ; Muir AW; Winslow E
    Br J Pharmacol; 1981 Oct; 74(2):381-8. PubMed ID: 7317687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of the ventricular anti-arrhythmia effects of oral and injectable mexiletine].
    Fauchier JP; Charbonnier B; Latour F; Brochier M; Raynaud R
    Ann Cardiol Angeiol (Paris); 1978; 27(2):173-8. PubMed ID: 655605
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-arrhythmic effects of mexiletine].
    Ledain L; Page A; Favreau L; Besse P
    Arch Mal Coeur Vaiss; 1982 May; 75(5):605-12. PubMed ID: 6180692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Well-controlled comparative study of the clinical effectiveness of intravenous mexiletine and procainamide on ventricular premature contraction.
    Arakawa K; Doi Y; Hashiba K; Mitsuoka T; Yanaga T; Hata Y; Ogawa N
    Jpn Heart J; 1984 May; 25(3):357-77. PubMed ID: 6206252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic and electrophysiological effects of intravenous injection of mexiletine].
    Tanaka T; Kusumoto M; Umemura J; Miyazawa Y; Suwa J; Komatsu Y
    Kokyu To Junkan; 1983 Dec; 31(12):1355-60. PubMed ID: 6676806
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of disopyramide, mexiletine and propafenon after intravenous and oral administration on left ventricular function in the M-mode echocardiogram].
    Böcker K; Köhler E; Seipel L; Loogen F
    Z Kardiol; 1982 Dec; 71(12):839-45. PubMed ID: 7164536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemodynamic effects of lidocaine and mexiletine in acute heart infarction].
    Keltai M; Kékány P; Mádai A
    Z Gesamte Inn Med; 1982 Aug; 37(15):507-9. PubMed ID: 7148050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mexiletine, an anti-arrhythmia agent for acute stage of myocardial infarction].
    Hayakawa H; Ino T
    Nihon Rinsho; 1983 Dec; 41(12):2748-55. PubMed ID: 6674559
    [No Abstract]   [Full Text] [Related]  

  • 19. [Modification by lidocain and other anti-arrhythmia agents on the combination of fixed and variably coupled ectopic ventricular beats].
    Burkhardt D; Steinbrunn W; Kaufmann G
    Schweiz Med Wochenschr; 1973 Dec; 103(50):1787-9. PubMed ID: 4768697
    [No Abstract]   [Full Text] [Related]  

  • 20. Adaptation of the dose of mexiletine according to pharmacokinetic data.
    Bogaert M
    Acta Cardiol Suppl; 1980; (25):67-73. PubMed ID: 6966454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.